DOCSLIB.ORG

University Hospitals Bristol NHS Foundation Trust Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
University Hospitals Bristol NHS Foundation Trust Annual Report University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2010 – 2011 University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2010 – 2011 Presented to Parliament pursuant to Schedule 7, paragraph 25(4) of the National Health Service Act 2006 Table of Contents 1. Chairman’s Statement ................................................................................................... 1 2. Chief Executive’s Foreword ........................................................................................... 3 Introduction........................................................................................................................ 3 Histopathology Inquiry ....................................................................................................... 3 Clinical services ................................................................................................................. 3 Research and innovation ................................................................................................... 4 Teaching and learning ....................................................................................................... 5 Board of Directors.............................................................................................................. 5 Looking forward ................................................................................................................. 6 3. Directors’ Report ............................................................................................................ 7 Principal activities of the Trust ........................................................................................... 7 Directors of the Trust ......................................................................................................... 7 Statement as to Disclosure to Auditors .............................................................................. 8 Business Review ............................................................................................................... 8 Our performance in 2010/11, an overview of regulatory risk ratings ............................... 8 Review of quarterly performance ................................................................................... 9 Annual performance against national access standards ................................................ 9 An overview of quality ...................................................................................................11 Contractual performance ..............................................................................................13 Research and Innovation ..............................................................................................14 Our wider role and future developments .......................................................................15 About our staff ..............................................................................................................17 Our values ....................................................................................................................25 Financial performance ..................................................................................................26 4. NHS Foundation Trust Code of Governance ................................................................34 Provisions of the Code .....................................................................................................34 A.1 – Board of Directors ...............................................................................................34 A.2 – Division of Responsibilities ..................................................................................35 C.1.10 – Nominations Committee .................................................................................35 C.2.3 – Information about Elected Governors Standing for Re-election ........................35 E.2.3 – Remuneration of the Non-executive Directors and Chairman ...........................36 Trust Board of Directors....................................................................................................37 Role and Function of the Trust Board of Directors ........................................................38 Membership and Attendance at Board and Committee Meetings ..................................39 Business Interests ........................................................................................................40 Audit and Assurance Committee ......................................................................................41 Internal Audit ................................................................................................................41 External Audit ...............................................................................................................42 Financial Reporting .......................................................................................................42 Other Assurance Functions ..........................................................................................43 Independence of the External Auditor in providing non-audit services ..........................43 Nomination and Appointments Committee ........................................................................43 Finance Committee ..........................................................................................................44 Governance and Risk Management Committee ...............................................................44 Remuneration Committee .................................................................................................45 Performance of the Trust Board of Directors and its Committees ..................................45 Membership Council .........................................................................................................46 Meetings of the Membership Council ............................................................................46 Appointment and removal of Non-Executive Directors ..................................................47 Business interests ........................................................................................................48 Foundation Trust membership ..........................................................................................48 Membership size and variations ...................................................................................48 Analysis of current membership ....................................................................................50 Developing a representative and engaged membership ...............................................50 Evaluation of steps to achieve a representative membership ........................................51 Elections .......................................................................................................................51 Membership Strategy ....................................................................................................52 Membership commentary .............................................................................................53 Public Constituencies ...................................................................................................53 Patient constituency ......................................................................................................53 Staff constituency .........................................................................................................53 Members communicating with their staff, public and patient governors .........................54 Governors by constituency – 1 April 2010 to 31 March 2011 ........................................55 Attendance at Membership Council and Nominations and Appointments Committee Meetings .......................................................................................................................58 5. Appendix A – Biographies of Members of the Trust Board of Directors .........................61 Chairman – John Savage .............................................................................................61 Chief Executive – Robert Woolley .................................................................................61 Non-executive Directors ...............................................................................................61 Executive Directors .......................................................................................................64 6. Appendix B – Remuneration Report .............................................................................66 7. Appendix C – Contact Details .......................................................................................71 Appendix D – Quality Report 2010/11 Appendix E – Annual Accounts 2010/11 Appendix F – Independent Auditors Report to the Board of Governors (Membership Council) 1. Chairman’s Statement Welcome to the Annual Report for University Hospitals Bristol NHS Foundation Trust for the year from 1 April 2010 to 31 March 2011. The Governors and I were delighted to appoint Robert Woolley as Chief Executive of the Trust in September 2010. Robert is providing the Trust with strong leadership as it moves into a time of significant change for the NHS: alterations to funding regimes and changes to the commissioning of services both come at a time of acute economic challenge. The year closes at 31st March with the Trust in a strong financial position and reporting an amber- green
Load more

Recommended publications
  • Annual Report and Accounts 2019/20
    University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2019/20 University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Schedule 7, paragraph 25 (4) (a) of the National Health Service Act 2006 © 2020 University Hospitals Bristol NHS Foundation Trust 4 | University Hospitals Bristol NHS Foundation Trust | Annual Report and Accounts 2019/20 Contents 1. Chairman’s Statement ....................................................................................... 7 2. Chief Executive’s Statement ............................................................................. 9 3. Performance Report ......................................................................................... 11 3.1 Overview ........................................................................................................................... 11 3.2 Performance Analysis ....................................................................................................... 21 3.3 Finance Review ................................................................................................................ 25 4. Sustainability Report ....................................................................................... 30 4.1 Overview ........................................................................................................................... 30 4.2 Policies .............................................................................................................................
    [Show full text]
  • University Hospitals Bristol NHS Foundation Trust – 93.0% February 2013; 94.2% Year to Date
    Performance Report For the governing body of South Gloucestershire CCG, to be tabled on 24 April 2013 1 Purpose The purpose of this report is to inform the board current performance of the services commissioned by South Gloucestershire CCG against key access and quality standards. The majority of the standards in this document show performance to February 2013 i.e. month 11 of the 2013/14 financial year, with the exception of urgent care performance standards which are shown to week ending 31 March 2013. The report is intended to provide a variety of level of details. The executive summary below details the current main performance concerns of the South West Commissioning Support Unit Performance Team and is therefore provides a quick overview of current issues. There is also a scorecard attached which shows current progress against all key standards. For a more in depth commentary on performance, the sections of this report will summarise the detail of performance against key standards for: Urgent Care Planned Care Cancer Stroke/TIA Quality indicators e.g. healthcare associated infections The Governing Body is asked to note the contents of the report. Executive Summary The main current areas of concern are shown in the table below: Area Standard Current Commentary Performance Urgent 4hrs: 95% of all As at week The whole health system has been experiencing severe Care patients to be ending 31/03/13: pressure for a number of months and this has been seen, treated, maintained recently, as is demonstrated by performance admitted or 4hrs: against urgent care standards. discharged NBT: 85.76% within 4hrs of UHB: 91.48% Patient flow remains at the core of the problem, although arrival at A&E recently an increase in activity due to issues with the launch of the NHS 111 system has increased pressure Ambulance Handovers: further.
    [Show full text]
  • Mixed Sex Accommodation ‐ Number of Breaches by Month (Provider Basis)
    Mixed Sex Accommodation ‐ Number of Breaches by Month (Provider basis) December January February March April May June July August September October November December Organisation Name Primary Care Trusts Bath And North East Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Bournemouth And Poole PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Cornwall And Isles Of Scilly PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Devon PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Dorset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Gloucestershire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ North Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Plymouth Teaching PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ South Gloucestershire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Torbay Care Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Wiltshire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Acute Trusts Dorset County Hospital NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Gloucestershire Hospitals NHS Foundation Trust 112 ‐‐‐‐‐‐‐‐‐‐‐‐ Great Western Hospitals NHS Foundation Trust 63 ‐‐‐‐‐‐‐‐‐‐‐‐ North Bristol NHS Trust 538 ‐‐‐‐‐‐‐‐‐‐‐‐ Northern Devon Healthcare NHS Trust 112 ‐‐‐‐‐‐‐‐‐‐‐‐ Plymouth Hospitals NHS Trust 23 ‐‐‐‐‐‐‐‐‐‐‐‐ Poole Hospital NHS Foundation Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Royal Cornwall Hospitals NHS Trust 81 ‐‐‐‐‐‐‐‐‐‐‐‐ Royal Devon And Exeter NHS Foundation Trust 133 ‐‐‐‐‐‐‐‐‐‐‐‐ Royal United Hospital Bath NHS Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Salisbury NHS Foundation Trust 67 ‐‐‐‐‐‐‐‐‐‐‐‐ South Devon Healthcare NHS Foundation Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Taunton And Somerset NHS Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ The Royal Bournemouth And Christchurch Hospitals NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ The Royal National Hospital For Rheumatic Diseases NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ University Hospitals Bristol NHS Foundation Trust 29 ‐‐‐‐‐‐‐‐‐‐‐‐
    [Show full text]
  • For Peer Review Only Journal: BMJ Open
    BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009090 on 11 September 2015. Downloaded from Repeat infusion of autologous bone marrow cells in multiple sclerosis – protocol for a phase I extension study (SIAMMS- II) For peer review only Journal: BMJ Open Manuscript ID: bmjopen-2015-009090 Article Type: Protocol Date Submitted by the Author: 15-Jun-2015 Complete List of Authors: Rice, Claire; University of Bristol, School of Clinical Sciences Marks, David; Bristol Royal Hospital for Children, Adult BMT Unit; University of Bristol, School of Clinical Sciences Walsh, Peter; North Bristol NHS Trust, Neurosciences Kane, Nick; North Bristol NHS Trust, Neurosciences Guttridge, Martin; NHS Blood and Transplant, Redondo, Juliana; University of Bristol, School of Clinical Sciences Sarkar, Pamela; University of Bristol, School of Clinical Sciences; North Bristol NHS Trust, Neurosciences Owen, Denise; North Bristol NHS Trust, Neurosciences Wilkins, Alastair; University of Bristol, School of Clinical Sciences; North Bristol NHS Trust, Neurosciences Scolding, Neil; University of Bristol Institute of Clinical Neurosciences, Neurology http://bmjopen.bmj.com/ <b>Primary Subject Neurology Heading</b>: Secondary Subject Heading: Haematology (incl blood transfusion) Multiple sclerosis < NEUROLOGY, IMMUNOLOGY, Bone marrow Keywords: transplantation < HAEMATOLOGY on September 30, 2021 by guest. Protected copyright. For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 1 of 11 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009090 on 11 September 2015. Downloaded from 1 2 3 Repeat infusion of autologous bone marrow cells in multiple sclerosis – a 4 phase I extension study (SIAMMS-II) 5 6 7 8 Claire M. Rice1,2*, David I.
    [Show full text]
  • North Bristol NHS Trust Quality Account 2020/21
    North Bristol NHS Trust Quality Account 2020/21 Exceptional healthcare, personally delivered Contents 04 Part 1: A statement on quality from the chief executive 08 Part 2: Priorities for improvement and statements of assurance from the board 2.1 Priorities for improvement: 09 Priority one: Ensure quality and safety of services is sustained whilst recovering from the impact of the COVID-19 pandemic; including: • Maintaining excellence in infection prevention and control • Ensuring the appropriate clinical priorities for recovery work • Keeping people waiting for planned care safe • Maintaining safety and excellent outcomes from emergency care 11 Priority two: Being outstanding for Safety—a national leader in implementing the NHS Patient Safety Strategy 13 Priority three: Ensuring excellence in our maternity services, delivering safe and effective maternity care 15 Priority four: Meeting the identified needs of patients with learning difficulties, autism, or both 2.2 Statements from the board 17 Review of services 19 Care Quality Commission 21 Research and Innovation 22 Operational Performance 27 Hospital Episode Statistics and DQIPs 28 Clinical Coding Performance 29 Clinical Coding Improvement Strategy 30 Data Security & Protection Toolkit 32 Part 3: Our quality indicators 3.1 Patient Safety 32 Patient Safety Indicators 33 Freedom to Speak Up 34 Guardian for safe working hours 35 Quality Indicators 37 Safeguarding Adults 38 Safeguarding Children 3.2 Clinical Effectiveness 39 Getting It Right First Time (GIRFT) - specialty outcomes 40 Mortality
    [Show full text]
  • Bristol Mayor, Marvin Rees, Opens BASF Wellbeing Day 2016
    Winter 2016-17 INSIDE: BASF NEWSLETTER Page 2 - Occupational Bristol Mayor, Therapy students experience life with BASF Marvin Rees, opens BASF Wellbeing Day 2016 BASF was hugely grateful to Mayor of Bristol, Marvin Rees, for opening our Wellbeing Day on 30th September 2016. He introduced the day with a brilliant personal account of the impact of stroke. As a young community worker, he supported an Page 10 - Fundraisers of individual on his journey to life after stroke. He supported him the Year raise awareness about stroke through supporting his personal challenge of climbing up PenYFan, attracting much media attention. Marvin Rees noted that it was not just the physical impact of stroke that people needed support with but also the emotional impact, and that families and carers also need support and the voluntary sector plays a key role in this. Page 12 - Service user to volunteer – Len Osgood’s stroke story BRISTOL AREA STROKE FOUNDATION The Gatehouse Centre, Hareclive Road, Hartcliffe, Bristol, BS13 9JN T: 0117 964 7657 Left to right: BASF Operations Manager, Rebecca Sheehy; [email protected] Bristol Mayor, Marvin Rees; Dr. Philip Clatworthy Consultant www.basf.uk.com Stroke neurologist at North Bristol NHS Trust; Dr Praveen Kumar, Charity number 287554 Senior Lecturer in Physiotherapy, University of West of England. continued on page 6 ➤ SUPPORTING PEOPLE AFFECTED BY STROKE continued on page 2 ➤ Dates for your diary 2017 ACTion After Stroke (4/5 weeks) Bristol Stroke Café Date: Tuesday 21st February – Tuesday 21st March Monthly, every
    [Show full text]
  • CQC Evidence Appendix
    North Bristol NHS Trust Evidence appendix North Bristol NHS Trust Date of inspection visit: Southmead Hospital 8 Nov to 29 Nov 2017 Southmead Road Bristol BS10 5NB Date of publication: 6 March 2018 Tel: 0117 950 5050 www.nbt.nhs.uk This evidence appendix provides the supporting evidence that enabled us to come to our judgements of the quality of service provided by this trust. It is based on a combination of information provided to us by the trust, nationally available data, what we found when we inspected, and information given to us from patients, the public and other organisations. For a summary of our inspection findings, see the inspection report for this trust. Facts and data about this trust Details of sites and locations registered with CQC Three locations are registered with the Care Quality Commission. Southmead Hospital Cossham Hospital Frenchay Hospital We only inspected Southmead Hospital as part of this inspection. Background to the trust North Bristol NHS Trust is an acute trust located in Bristol that provides acute hospital and some community services to a population of about 900,000 people in Bristol, South Gloucestershire and North Somerset. The trust is not a foundation trust. It also provides specialist services such as neurosciences, renal, trauma and plastics/burns to people from across the South West and in some instances nationally or internationally. The new hospital at Southmead opened in May 2014 when the main hospital at Frenchay closed. Southmead Hospital provides a full range of acute clinical services. The trust also provides community healthcare for children and young people.
    [Show full text]
  • North Bristol NHS Trust Strategy 2016-2021
    North Bristol NHS Trust Strategy 2016-2021 Contents 1 Executive summary 04 2 Introduction 06 3 Our values and vision 08 4 Strategic themes 10 5 Next steps and delivery plan 20 6 Conclusion 22 7 Appendix A: North Bristol NHS Trust today 24 8 Appendix B: The challenges we face 30 1 | Executive summary North Bristol NHS Trust Achieving our vision to provide This strategy has been the high quality care that we developed for the period 2016 - is a provider of local aspire to within the resources 2021 to provide focus and clarity hospital services and available is an increasing of direction for our organisation complex specialist care challenge. By improving patient and its stakeholders. It takes flow, maximising productivity, into account detailed analysis for a large population using resources including our of the Trust, activity, quality, in the South West of workforce wisely, and sharing performance, outcomes, England. Employing over best practice across the Trust, opportunities and challenges, our finances will be sustainable and is informed by clinician, 8,000 highly skilled and and we will meet the national staff and patient views. caring staff, we aim to standards for operational The detail of this analysis is performance in the coming described in appendices A & B: deliver excellent clinical years. The aims described in The eight strategic themes that outcomes and a great this strategy are designed to will form the basis of our plans create an organisation in which experience for all service over the next five years are: the necessary savings and users: exceptional efficiencies are delivered to 1) Change how we deliver healthcare, personally enable us to do more with the services to generate delivered.
    [Show full text]
  • 1 Reference: FOI 27719 BNSSG 15C Subject: Facial Nerve Palsy I Can
    Reference: FOI 27719 BNSSG 15C Subject: Facial Nerve Palsy I can confirm that the CCG does hold some of the information requested; please see responses below: QUESTION RESPONSE Bristol, North Somerset and South Gloucestershire CCG does not hold this 1. Of those with facial nerve palsy who have information. The provider trusts may be able to not made a full or nearly full recovery at provide this information. If you would like to 12 weeks following onset, can you redirect your Freedom of information request provide an estimate of the percentage of please follow the links. such patients who are referred for rehabilitation of persistent facial University Hospitals Bristol NHS Foundation pain/discomfort and dysfunction? Trust North Bristol NHS Trust Persistent facial nerve palsy – most common presentation (outside of surgical complication, in which case referral would come from the surgical team, not primary care) – the CCG would follow the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries (CKS) as below: Refer urgently to neurology or to ear, nose, and throat (ENT) if there is: o Any doubt regarding the diagnosis. o Recurrent Bell's palsy. 2. If a patient with facial nerve palsy is o Bilateral Bell's palsy. routinely referred to secondary care for If the cornea remains exposed after rehabilitation therapy, which hospital(s) attempting to close the eyelid, refer urgently and department(s) do you refer to? to ophthalmology. If the paralysis shows no sign of improvement after 1 month, or there is suspicion of a serious underlying diagnosis (for example, cholesteatoma, parotid tumour, malignant otitis externa), refer urgently to ENT.
    [Show full text]
  • Choosing Your Hospital, Contact: Choosing Your Hospital
    hospital North Somerset Primary Care Trust your Choosing PHOTOGRAPHY COPYRIGHT: ALAMY, GETTY, JOHN BIRDSALL, NHS LIBRARY, REX, SPL, ZEFA/CORBIS copy of this booklet is also Crown copyright 2005. available on: www.nhs.uk A Tel: 01454 883655 BS37 4AF Bristol Yate 248 Station Road Chipping Sodbury Memorial Day Centre Referral Management Centre Patient Choice Coordinator For more help with choosing your hospital, contact: © 270744/151 What is patient choice? Things to think about If you and your GP decide that you need to see a specialist Where can I go for treatment? for further treatment, you can now choose where to have You might already have experience of a particular hospital or know someone who has. Now you can choose – where would you like to go? Or, if you like, your treatment from a list of hospitals or clinics. From April, your GP can recommend a hospital where you can be treated. you may have an even bigger choice – full details will be How do I find out more information on the NHS website (www.nhs.uk). about my condition? Your GP should be able to give you the answers to some of the questions This guide explains more about how the process works. you have. Or contact NHS Direct: visit www.nhsdirect.nhs.uk or call It also gives you answers to some questions you may have. 0845 4647 and ask to speak to a health information advisor. Plus, there are details of the hospitals you can choose and How long will it take? some information to help you choose the one that will be How quickly do you want to be treated? Would you be willing to travel best for you.
    [Show full text]
  • North Bristol NHS Trust Job Description
    North Bristol NHS Trust Exceptional healthcare, personally delivered Job Description SECTION 1 – JOB DETAILS Job Title: Consultant Histopathologist Division: Core Clinical Services Location/Base: Southmead Hospital, Bristol SECTION 2 – THE WORK OF THE DEPARTMENT North Bristol NHS Trust is seeking a full-time (10 PAs) substantive Consultant Histopathologist within the Department of Cellular Pathology. This is a replacement post. It is expected that the appointee will have an established or developing interest in Gastrointestinal (GI) Pathology and will join a team of 3 specialists and 4 non-care GI Pathologists. As we are growing our service across all sub-specialisms, additional interest in Head and Neck Pathology and Endocrine Pathology is highly desirable. Severn Pathology Severn Pathology lies at the heart of patient care. Severn Pathology’s mission is to provide a best in class, high quality, innovative, value for money Pathology service that serves the needs of the healthcare market in the South West region and beyond. In doing so, we will strive to put Pathology at the heart of a modern patient pathway, serving an increasingly diverse market. The combination of general pathology services with a thriving and growing genetics laboratory service will ensure continued development of state of the art pathology services in to the future. On 1 May 2016, North Bristol NHS Trust’s (NBT) Department of Cellular Pathology and the Department of Histopathology at the University Hospitals Bristol NHS Foundation Trust (UHB) merged and co-located the bulk on their services to a new, purpose-built facility on the Southmead Hospital site. The service is managed by NBT which also manages the Essential Services Laboratory and Paediatric / Perinatal mortuary located on UHB premises.
    [Show full text]
  • 2025 Embracing Change, Proud to Care
    1 2 Contents Foreword 4 Introduction – Refreshing our strategy 6 Section one - Our strategic context 8 Who we are 8 Where we are in 2019 – Our case for change 13 Summary – What we need to focus on for 2025 23 Section two - Our strategy for 2025 25 Our mission, vision and values 25 Our strategic priorities 26 Our strategic choices 27 Our strategic priorities and objectives 29 Section three - Implementing our strategy 32 Specialist and regional services 33 Local acute services and integrated care 36 Education and workforce 39 Research and innovation 42 Section four - Our enabling strategies 46 Our integrated strategy framework 46 Our people strategy 46 Our quality strategy 47 Our digital strategy 48 Our improvement and innovation strategy 48 Our finance strategy 49 Our estate strategy 50 Our communications strategy 50 Section five - Governance, assurance and communication 51 3 Foreword A strategy is only as good as the leadership commitment and financial resources that go into making it happen. University Hospitals Bristol NHS Foundation Trust (UH Bristol) has a solid track record over the last decade of setting ambitious strategic plans and delivering them. We have invested over £200million in new or expanded hospital facilities, most noticeably in the Bristol Heart Institute, Bristol Royal Infirmary, Bristol Royal Hospital for Children and the Bristol Haematology and Oncology Centre. We have grown and enhanced our range of specialist services for the people of the South West, South Wales and further afield. We are one of only a few acute hospital Trusts nationwide to have been awarded an Outstanding rating from the Care Quality Commission and we have achieved Global Digital Exemplar status for our work to transform healthcare through better use of information technology.
    [Show full text]